Executive Profile

Rolf M. Zinkernagel Ph.D., M.D. Co-Founder and Member of Scientific Advisory Board, Telormedix SA

Age	Total Calculated Compensation	This person is connected to 10 Board Members in 10 different organizations across 12 different industries. See Board Relationships
68	--

Background

Dr. Rolf M. Zinkernagel, M.D., Ph.D. is a Venture Partner and Scientific Partner of Aravis SA and focuses on life sciences. Dr. Zinkernagel serves as Scientific and Clinical Advisor of GANYMED Pharmaceuticals AG. He serves as a Science Consultant to GenPat 77, Aponetics AG, Solis Therapeutics and Ganymed. He co-founded Telormedix SA in 2007 and served as its Advisor. Dr. Zinkernagel specializes in infectious diseases and immunopathology and is a pioneer in immunological ... research on cell-mediated and antibody responses against viruses. Dr. Zinkernagel served as a a Scientific and Strategic Advisor at XBiotech USA, Inc. Since 1992, he served as the Head of the Institute of Experimental Immunology, Department of Pathology at the University of Zurich, Switzerland. He serves as a Director at Novartis Institutes for BioMedical Research, Inc. Dr. Zinkernagel has been an Independent & Non-Executive Director of Novartis AG of Novartis India Ltd. since 1999. He has been a Director at Novartis Consumer Health, Inc. since 1999. He serves as a Member of the Board of Directors and a Member of the Scientific Advisory Board of Schlieren. He serves as a Member of the Scientific Advisory Board at Cytos Biotechnology AG, The Lombard Odier Darier Hentsch & Cie Bank, BT & T, Bio-Alliance Capital, Aravis General Partner Ltd., Bioxell, Esbatech, Novimmune SA, and Sylmar. He has been a Member of Scientific Advisory Board at Nuvo Research Inc. since September 2005. He serves as a Member of Scientific Advisory Board at Imvision Therapeutics Inc. He serves as a Member of Scientific-Advisory-Board at Telormedix SA and a Member of Scientific Advisory Council at Cancer Research Institute, Inc. Until 2003, Dr. Zinkernagel served as a Member of the Board of Directors of Cytos Biotechnology. He served as a Member of the Scientific Advisory Board of MannKind Corp. Dr. Zinkernagel is a Member of the Executive Board of the International Union of Immunological Societies. He is a Member of the Swiss Society of Allergy and Immunology, the American Associations of Immunologists and of Pathologists, the ENI European Network of Immunological Institutions, and the International Society for Antiviral Research. Since 1992, Dr. Zinkernagel has been a Professor at the University of Zurich, Switzerland. Among many other honors and awards for his contributions to Science, he received the Nobel Prize in Medicine in 1996. He is a most distinguished Medical Researcher and Immunologist. He holds a Ph.D. from the Australian National University and graduated from the University of Basel with an M.D. in 1970. He has a Master's Degree in Experimental Medicine from Universität Zürich. He also attended Université de Lausanne.

Corporate Headquarters Via della Posta 10 Bioggio, Ticino 6934 Switzerland Phone: 41 91 610 70 00 Fax: 41 91 610 70 31 Board Members Memberships Director Novartis Institutes for BioMedical Research, Inc. 1999-Present Independent & Non-Executive Director and Member of Corporate Governance & Nomination Committee Novartis AG 1999-Present Director Novartis Consumer Health, Inc. Education MD 1970 Universität Basel PhD Australian National University Master's Degree Universität Zürich Unknown/Other Education Université de Lausanne Other Affiliations NovImmune SA Novartis AG Cytos Biotechnology AG Nuvo Research Inc. Aravis SA GANYMED Pharmaceuticals AG Novartis Consumer Health, Inc. Universität Zürich Australian National University Universität Basel Université de Lausanne Novartis Institutes for BioMedical Research, Inc. MannKind Corp. Cancer Research Institute, Inc. Imvision Therapeutics Inc XBiotech USA, Inc.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.